{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:05:26Z","timestamp":1784286326201,"version":"3.55.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006942","name":"Medical University of South Carolina","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006942","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Pediatric cutaneous mastocytosis is a heterogeneous mast cell disorder that typically presents as cutaneous disease with a benign and self-limiting course. Despite its favorable prognosis, children with cutaneous mastocytosis may experience symptom-related effects on daily functioning that have not been comprehensively characterized. Data on sleep disturbances and QoL in pediatric cutaneous mastocytosis, unfortunately, remain limited. This study aimed to evaluate the relationship between sleep parameters and dermatology-related QoL and assess whether disease severity modifies the association between sleep disturbances and QoL. Thirty-five children with confirmed cutaneous mastocytosis and 50 healthy controls were enrolled. Disease severity was assessed with SCORing MAstocytosis (SCORMA) Index. Sleep characteristics were evaluated with Children\u2019s Sleep Habits Questionnaire (CSHQ), and dermatology-related QoL was assessed with Children\u2019s Dermatology Life Quality Index (CDLQI). Children with cutaneous mastocytosis exhibited significantly higher total CSHQ scores compared with controls (median 47.0 vs 39.0, respectively) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.004), with a markedly higher proportion exceeding the clinical screening threshold for sleep disturbance (85.7% vs 31.4%, respectively) (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001). Patients demonstrated increased bedtime resistance, sleep anxiety, night wakings, parasomnias, and daytime sleepiness. CDLQI impairment was generally mild, with 94.2% of patients reporting no or small impact. CDLQI scores correlated strongly with SCORMA scores (\n                    <jats:italic>\u03c1<\/jats:italic>\n                    \u2009=\u20090.57,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001) but were not significantly associated with overall sleep disturbance.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    :\u00a0Children with cutaneous mastocytosis frequently exhibit sleep disturbances, whereas the impact on dermatology-related QoL was generally mild in most patients. Notably, sleep problems were highly prevalent even when dermatology-related QoL impact was minimal, indicating that dermatology-specific QoL instruments may not fully capture the sleep-related burden of pediatric cutaneous mastocytosis. These findings support the integration of routine sleep and dermatology-related QoL screening into the comprehensive management of pediatric cutaneous mastocytosis.\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Cutaneous mastocytosis in children generally has a favorable prognosis, but symptoms such as pruritus and flushing may affect daily functioning.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Data regarding sleep disturbances and dermatology-related quality of life in pediatric cutaneous mastocytosis are limited.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td align=\"left\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Children with cutaneous mastocytosis had significantly more sleep disturbances than healthy controls, with most patients exceeding the clinical screening threshold for sleep problems.<\/jats:italic>\n                              \u2022\n                              <jats:italic>Sleep disturbances were common even among patients reporting minimal impairment in dermatology-related quality of life, suggesting that dermatology-specific QoL measures may underestimate disease burden.<\/jats:italic>\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-07148-2","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T15:08:09Z","timestamp":1782400089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sleep disturbances and dermatology-related quality of life in children with cutaneous mastocytosis: a patient-centered perspective"],"prefix":"10.1007","volume":"185","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0818-8063","authenticated-orcid":false,"given":"Leman Tuba","family":"Karakurt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8297-1315","authenticated-orcid":false,"given":"P\u0131nar Ya\u011fmur","family":"Alt\u0131nkaynak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-321X","authenticated-orcid":false,"given":"Dilek","family":"Kacar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6910-4340","authenticated-orcid":false,"given":"Ay\u015fe Cavidan","family":"Sonkur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0940-7398","authenticated-orcid":false,"given":"Mustafa","family":"Arga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"11","key":"7148_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000646","volume":"5","author":"P Valent","year":"2021","unstructured":"Valent P, Akin C, Hartmann K, Reiter A, Gotlib J, Sotlar K et al (2021) Updated diagnostic criteria and classification of mast cell disorders: a consensus proposal. HemaSphere 5(11):e646. https:\/\/doi.org\/10.1097\/HS9.0000000000000646","journal-title":"HemaSphere"},{"issue":"11","key":"7148_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s11882-017-0748-4","volume":"17","author":"N Klaiber","year":"2017","unstructured":"Klaiber N, Kumar S, Irani AM (2017) Mastocytosis in children. Curr Allergy Asthma Rep 17(11):80. https:\/\/doi.org\/10.1007\/s11882-017-0748-4","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"7148_CR3","doi-asserted-by":"publisher","first-page":"e2021069","DOI":"10.4084\/MJHID.2021.069","volume":"13","author":"F Giona","year":"2021","unstructured":"Giona F (2021) Pediatric mastocytosis: an update. Mediterr J Hematol Infect Dis 13(1):e2021069. https:\/\/doi.org\/10.4084\/MJHID.2021.069","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"2","key":"7148_CR4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/pde.13066","volume":"34","author":"A Heinze","year":"2017","unstructured":"Heinze A, Kuemmet TJ, Chiu YE, Galbraith SS (2017) Longitudinal study of pediatric urticaria pigmentosa. Pediatr Dermatol 34(2):144\u20139. https:\/\/doi.org\/10.1111\/pde.13066","journal-title":"Pediatr Dermatol"},{"issue":"11","key":"7148_CR5","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.3390\/v13112245","volume":"13","author":"M Krapi\u0107","year":"2021","unstructured":"Krapi\u0107 M, Kavazovi\u0107 I, Wensveen FM (2021) Immunological mechanisms of sickness behavior in viral infection. Viruses 13(11):2245. https:\/\/doi.org\/10.3390\/v13112245","journal-title":"Viruses"},{"issue":"2","key":"7148_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1159\/000048188","volume":"127","author":"M Castells","year":"2002","unstructured":"Castells M, Austen KF (2002) Mastocytosis: mediator-related signs and symptoms. Int Arch Allergy Immunol 127(2):147\u2013152. https:\/\/doi.org\/10.1159\/000048188","journal-title":"Int Arch Allergy Immunol"},{"issue":"3","key":"7148_CR7","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/adc.84.3.205","volume":"84","author":"C Eiser","year":"2001","unstructured":"Eiser C, Morse R (2001) A review of measures of quality of life for children with chronic illness. Arch Dis Child 84(3):205\u2013211. https:\/\/doi.org\/10.1136\/adc.84.3.205","journal-title":"Arch Dis Child"},{"issue":"4","key":"7148_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1080\/00015550152572912","volume":"81","author":"R Heide","year":"2001","unstructured":"Heide R, Middelkamp Hup MA, Mulder PGH, Oranje AP, Mastocytosis Study Group Rotterdam (2001) Clinical scoring of cutaneous mastocytosis. Acta Derm Venereol 81(4):273\u2013276. https:\/\/doi.org\/10.1080\/00015550152572912","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 1","key":"7148_CR9","first-page":"121","volume":"163","author":"A Waters","year":"2010","unstructured":"Waters A, Sandhu D, Beattie P, Ezughah F, Lewis-Jones S (2010) Severity stratification of children\u2019s dermatology life quality index (CDLQI) scores. Br J Dermatol 163:121","journal-title":"Br J Dermatol"},{"issue":"11","key":"7148_CR10","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1365-4632.2006.02881.x","volume":"45","author":"S Ozt\u00fcrkcan","year":"2006","unstructured":"Ozt\u00fcrkcan S, Ermertcan AT, Eser E, Sahin MT (2006) Cross-validation of the Turkish version of the Dermatology Life Quality Index. Int J Dermatol 45(11):1300\u20131307. https:\/\/doi.org\/10.1111\/j.1365-4632.2006.02881.x","journal-title":"Int J Dermatol"},{"issue":"8","key":"7148_CR11","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/sleep\/23.8.1d","volume":"23","author":"JA Owens","year":"2000","unstructured":"Owens JA, Spirito A, McGuinn M (2000) The Children\u2019s Sleep Habits Questionnaire (CSHQ): psychometric properties of a survey instrument for school-aged children. Sleep 23(8):1043\u20131051","journal-title":"Sleep"},{"issue":"6","key":"7148_CR12","first-page":"493","volume":"52","author":"NP Fi\u015f","year":"2010","unstructured":"Fi\u015f NP, Arman AR, Ay P, Topuzo\u011flu A, G\u00fcler AS, Imren SG et al (2010) Validation of the Turkish version of the Children\u2019s Sleep Habits Questionnaire. Turk J Pediatr 52(6):493\u2013499","journal-title":"Turk J Pediatr"},{"issue":"4","key":"7148_CR13","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.anai.2019.12.020","volume":"124","author":"MR Vermeiren","year":"2020","unstructured":"Vermeiren MR, Kranenburg LW, van Daele PLA, Gerth van Wijk R, Hermans MAW (2020) Psychological functioning and quality of life in patients with mastocytosis: a cross-sectional study. Ann Allergy Asthma Immunol 124(4):373\u20138. https:\/\/doi.org\/10.1016\/j.anai.2019.12.020","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"11","key":"7148_CR14","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/jpm13111562","volume":"13","author":"LB Weinstock","year":"2023","unstructured":"Weinstock LB, Nelson RM, Blitshteyn S (2023) Neuropsychiatric manifestations of mast cell activation syndrome and response to mast-cell-directed treatment: a case series. J Pers Med 13(11):1562. https:\/\/doi.org\/10.3390\/jpm13111562","journal-title":"J Pers Med"},{"issue":"10","key":"7148_CR15","doi-asserted-by":"publisher","first-page":"adv00583","DOI":"10.2340\/actadv.v101.350","volume":"101","author":"D Kwiatkowska","year":"2021","unstructured":"Kwiatkowska D, Reich A (2021) Role of mast cells in the pathogenesis of pruritus in mastocytosis. Acta Derm Venereol 101(10):adv00583. https:\/\/doi.org\/10.2340\/actadv.v101.350","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"7148_CR16","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1016\/j.jaip.2020.12.007","volume":"9","author":"F Bawany","year":"2021","unstructured":"Bawany F, Northcott CA, Beck LA, Pigeon WR (2021) Sleep disturbances and atopic dermatitis: relationships, methods for assessment, and therapies. J Allergy Clin Immunol Pract 9(4):1488\u20131500. https:\/\/doi.org\/10.1016\/j.jaip.2020.12.007","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"7148_CR17","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/j.jaci.2018.08.005","volume":"142","author":"YS Chang","year":"2018","unstructured":"Chang YS, Chiang BL (2018) Sleep disorders and atopic dermatitis: a two-way street? J Allergy Clin Immunol 142(4):1033\u20131040. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.005","journal-title":"J Allergy Clin Immunol"},{"issue":"8","key":"7148_CR18","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1016\/j.jaip.2022.05.034","volume":"10","author":"J Gotlib","year":"2022","unstructured":"Gotlib J, Schwaab J, Shomali W, George TI, Radia DH, Castells M et al (2022) Proposed European Competence Network on Mastocytosis\u2013American Initiative in Mast Cell Diseases (ECNM-AIM) response criteria in advanced systemic mastocytosis. J Allergy Clin Immunol Pract 10(8):2025\u20132038. https:\/\/doi.org\/10.1016\/j.jaip.2022.05.034","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"7148_CR19","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/pde.14952","volume":"39","author":"E Wojtyna","year":"2022","unstructured":"Wojtyna E, Lewicka W, Ma\u0142yszczak A, Kotulska A, Brzosko M, Doniec Z (2022) Psychometric properties of the Children\u2019s Dermatology Life Quality Index in pediatric localized scleroderma. Pediatr Dermatol 39(2):234\u2013241. https:\/\/doi.org\/10.1111\/pde.14952","journal-title":"Pediatr Dermatol"},{"issue":"8","key":"7148_CR20","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/archpedi.159.8.745","volume":"159","author":"SL Chamlin","year":"2005","unstructured":"Chamlin SL, Mattson CL, Frieden IJ, Williams ML, Mancini AJ, Cella D et al (2005) The price of pruritus: sleep disturbance and cosleeping in atopic dermatitis. Arch Pediatr Adolesc Med 159(8):745\u2013750. https:\/\/doi.org\/10.1001\/archpedi.159.8.745","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"7148_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.smrv.2010.01.004","volume":"14","author":"D Camfferman","year":"2010","unstructured":"Camfferman D, Kennedy JD, Gold M, Martin AJ, Lushington K (2010) Eczema and sleep and its relationship to daytime functioning in children. Sleep Med Rev 14(6):359\u2013369. https:\/\/doi.org\/10.1016\/j.smrv.2010.01.004","journal-title":"Sleep Med Rev"},{"issue":"6","key":"7148_CR22","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.5114\/ada.2021.108435","volume":"38","author":"N Spolak-Bobryk","year":"2021","unstructured":"Spolak-Bobryk N, Niedoszytko M, Jassem E, Che\u0142mi\u0144ska M, Lange M, Majkowicz M et al (2021) Assessing quality of life in patients with mastocytosis: development of the disease-specific questionnaire. Postepy Dermatol Alergol 38(6):1044\u20131051. https:\/\/doi.org\/10.5114\/ada.2021.108435","journal-title":"Postepy Dermatol Alergol"},{"issue":"1","key":"7148_CR23","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s13023-022-02439-x","volume":"17","author":"TJ Schmidt","year":"2022","unstructured":"Schmidt TJ, Sellin J, Molderings GJ, Conrad R, M\u00fccke M (2022) Health-related quality of life and health literacy in patients with systemic mastocytosis and mast cell activation syndrome. Orphanet J Rare Dis 17(1):295. https:\/\/doi.org\/10.1186\/s13023-022-02439-x","journal-title":"Orphanet J Rare Dis"},{"issue":"23","key":"7148_CR24","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.3390\/diagnostics13233583","volume":"13","author":"H \u0141ugowska-Umer","year":"2023","unstructured":"\u0141ugowska-Umer H, Czarny J, Rydz A, Nowicki RJ, Lange M (2023) Current challenges in the diagnosis of pediatric cutaneous mastocytosis. Diagnostics (Basel) 13(23):3583. https:\/\/doi.org\/10.3390\/diagnostics13233583","journal-title":"Diagnostics (Basel)"},{"issue":"3","key":"7148_CR25","doi-asserted-by":"publisher","first-page":"123","DOI":"10.5152\/TurkPediatriArs.2016.2418","volume":"51","author":"Z Tamay","year":"2016","unstructured":"Tamay Z, \u00d6z\u00e7eker D (2016) Current approach to cutaneous mastocytosis in childhood. Turk Pediatri Ars 51(3):123\u2013127. https:\/\/doi.org\/10.5152\/TurkPediatriArs.2016.2418","journal-title":"Turk Pediatri Ars"},{"issue":"4","key":"7148_CR26","doi-asserted-by":"publisher","first-page":"311","DOI":"10.14744\/cpr.2023.54254","volume":"45","author":"\u00d6 \u00d6zdemir","year":"2023","unstructured":"\u00d6zdemir \u00d6, Sava\u015fan S (2023) Cutaneous mastocytosis in childhood: an update from the literature. J Clin Pract Res 45(4):311\u2013320. https:\/\/doi.org\/10.14744\/cpr.2023.54254","journal-title":"J Clin Pract Res"},{"issue":"1","key":"7148_CR27","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/cea.14249","volume":"53","author":"RC Knibb","year":"2023","unstructured":"Knibb RC, Huissoon AP, Baretto R, Ekbote A, Onyango-Odera S, Screti C et al (2023) The impact of anaphylaxis on the quality of life and mental health of adults. Clin Exp Allergy 53(1):121\u20135. https:\/\/doi.org\/10.1111\/cea.14249","journal-title":"Clin Exp Allergy"},{"issue":"1","key":"7148_CR28","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2500\/aap.2017.38.4002","volume":"38","author":"J Ogg","year":"2017","unstructured":"Ogg J, Wong J, Wan MW, Davis N, Arkwright PD (2017) Factors that determine parents\u2019 perception of their child\u2019s risk of life-threatening food-induced anaphylaxis. Allergy Asthma Proc 38(1):44\u201353. https:\/\/doi.org\/10.2500\/aap.2017.38.4002","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"7148_CR29","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.iac.2018.04.001","volume":"38","author":"A Matito","year":"2018","unstructured":"Matito A, Aza\u00f1a JM, Torrelo A, Alvarez-Twose I (2018) Cutaneous mastocytosis in adults and children: new classification and prognostic factors. Immunol Allergy Clin N Am 38(3):351\u2013363. https:\/\/doi.org\/10.1016\/j.iac.2018.04.001","journal-title":"Immunol Allergy Clin N Am"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07148-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07148-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:25:31Z","timestamp":1784283931000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07148-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":29,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7148"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07148-2","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"27 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Istanbul Medeniyet University (No: 2025\/0216).","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the parents or legal guardians of all participating children, and assent was obtained from children when appropriate.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"525"}}